These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22659624)

  • 1. Population pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers.
    Zhang DM; Wang K; Zhao X; Li YF; Zheng QS; Wang ZN; Cui YM
    Acta Pharmacol Sin; 2012 Nov; 33(11):1387-94. PubMed ID: 22659624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, pharmacodynamics, tolerability and safety of single doses of bivalirudin in healthy chinese subjects.
    Zhang D; Wang Z; Zhao X; Lu W; Gu J; Cui Y
    Biol Pharm Bull; 2011; 34(12):1841-8. PubMed ID: 22130240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender.
    Robson R; White H; Aylward P; Frampton C
    Clin Pharmacol Ther; 2002 Jun; 71(6):433-9. PubMed ID: 12087346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting and evaluating the effect of bivalirudin in cardiac surgical patients.
    Zhao Q; Edrich T; Paschalidis ICh
    IEEE Trans Biomed Eng; 2014 Feb; 61(2):435-43. PubMed ID: 24013828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis.
    O'Brien SH; Yee DL; Lira J; Goldenberg NA; Young G
    J Thromb Haemost; 2015 Sep; 13(9):1615-22. PubMed ID: 26180006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001, a Recently Developed Generic of Bivalirudin.
    Han S; Kim YH; Choi HY; Kim MJ; Kim WJ; Park H; Bae KS; Lim HS
    Pharm Res; 2019 Aug; 36(10):146. PubMed ID: 31396727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review.
    Zaleski KL; DiNardo JA; Nasr VG
    Anesth Analg; 2019 Jan; 128(1):43-55. PubMed ID: 29461391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric catheterization laboratory anticoagulation with bivalirudin.
    Forbes TJ; Hijazi ZM; Young G; Ringewald JM; Aquino PM; Vincent RN; Qureshi AM; Rome JJ; Rhodes JF; Jones TK; Moskowitz WB; Holzer RJ; Zamora R
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):671-9. PubMed ID: 21433272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M; Fujimori Y; Nakamura S; Kondo Y; Kuroda Y; Oka S; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2019 Dec; 72(12):817-824. PubMed ID: 31366633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics of Lithium Carbonate in Young Male Healthy Chinese Volunteers.
    Yu W; Sun X; Li Y; Li M; Wang K; Li H
    Pharmacopsychiatry; 2016 Sep; 49(5):177-181. PubMed ID: 27124003
    [No Abstract]   [Full Text] [Related]  

  • 11. Adaptive control of bivalirudin in the cardiac intensive care unit.
    Zhao Q; Edrich T; Paschalidis IC
    IEEE Trans Biomed Eng; 2015 Feb; 62(2):638-647. PubMed ID: 25314695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD
    Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?
    Angeli F; Reboldi G
    Am J Cardiovasc Drugs; 2015 Aug; 15(4):221-4. PubMed ID: 26088534
    [No Abstract]   [Full Text] [Related]  

  • 14. Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin.
    Zafar MU; Vorchheimer DA; Tewar MP; Giannarelli C; Crippa M; Sartori S; Rodriguez D; Baber U; Mehran R; Badimon JJ
    Thromb Haemost; 2014 Nov; 112(5):1069-70. PubMed ID: 25104302
    [No Abstract]   [Full Text] [Related]  

  • 15. Bivalirudin: in patients with acute coronary syndromes : planned for urgent or early intervention.
    Deeks ED; Curran MP
    Drugs; 2008; 68(16):2345-56. PubMed ID: 18973397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CytoSorb on kinetics of vancomycin and bivalirudin in critically ill patients.
    Scandroglio AM; Pieri M; Nardelli P; Fominskiy E; Calabrò MG; Melisurgo G; Ajello S; Pappalardo F
    Artif Organs; 2021 Sep; 45(9):1097-1103. PubMed ID: 33686696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a LC-MS/MS method for determination of bivalirudin in human plasma: Application to a clinical pharmacokinetic study.
    Pan G; Wang X; Huang Y; Gao X; Wang Y
    J Pharm Biomed Anal; 2010 May; 52(1):105-9. PubMed ID: 20042308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the effects of bivalirudin in cardiac surgical patients.
    Edrich T; Frendl G; Rawn JD; Paschalidis Y
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():120-3. PubMed ID: 22254265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalirudin: a review of pharmacology and therapeutic use.
    Scholle JM; White CM
    Conn Med; 2010; 74(10):595-7. PubMed ID: 21189716
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of bivalirudin in patients with renal impairment.
    Robson R
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():33F-6. PubMed ID: 11156732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.